Impact of Neoadjuvant Therapy on Oncological Outcomes of Patients With Distal Pancreatic Adenocarcinoma

NAT is associated with improved PFS and OS in patients with -D-PDAC. Further randomized controlled trials are warranted to confirm these findings.

Authors

Asmita Chopra (ORCID: https://orcid.org/0000-0002-5908-3993)
Hussein H. Khachfe (ORCID: https://orcid.org/0000-0001-7537-9033)
Aatur Dilip Singhi (ORCID: https://orcid.org/0000-0003-3930-7096)
Samer AlMasri
Ibrahim Nassour (ORCID: https://orcid.org/0000-0002-9845-1074)
Sowmya Narayanan (ORCID: https://orcid.org/0000-0002-0725-9731)
Alessandro Paniccia (ORCID: https://orcid.org/0000-0001-7047-1711)
Anthony Gebran (ORCID: https://orcid.org/0000-0003-3311-9908)
Amer H. Zureikat (ORCID: https://orcid.org/0000-0002-7800-5464)
Kenneth Lee (ORCID: https://orcid.org/0000-0001-6148-1133)
Rudy El Asmar